The diffusing capacity in adult cystic fibrosis

Area of Science:

• Pulmonary Medicine
• Respiratory Physiology

Background:

• Diffusing capacity for carbon monoxide (DLCO) adjusted for lung volume is valuable in lung diseases.
• Its utility in cystic fibrosis (CF) pulmonary function testing is not well-established.
• CF primarily affects airways, with variable impact on alveolar-capillary units.

Purpose of the Study:

• To evaluate if DLCO adjusted for alveolar volume (V(A)%) correlates with pulmonary dysfunction severity in adult CF patients.
• To compare the clinical significance of adjusted vs. unadjusted DLCO in CF.

Main Methods:

• Analysis of pulmonary function test data from 52 adult CF patients.
• Calculation and correlation of diffusing capacity of carbon monoxide by single breath method (DLCO(SB)) and DLCO(SB)/V(A)% with airflow limitation and air trapping measures.
• Statistical analysis including Pearson correlation coefficients and P-values.

Main Results:

• Unadjusted DLCO(SB) remained in the reference range except in severe impairment.
• DLCO(SB) showed significant positive correlation with airflow limitation and negative correlation with air trapping.
• DLCO(SB)/V(A)% remained high, showing no correlation with other lung function measures.
• Adjusted DLCO(SB) and DLCO(SB)/V(A)% decreased with worsening lung disease and correlated with airflow limitation and air trapping.

Conclusions:

• Adjusting DLCO for lung volume (DLCO(SB)/V(A)%) provides a more sensitive marker of pulmonary dysfunction in CF than unadjusted DLCO(SB).
• The preserved adjusted DLCO values until late stages may reflect CF's predominant airway pathology and preserved alveolar-capillary units.
• Adjusted DLCO is a valuable tool for monitoring CF progression and assessing disease severity.